Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.
about
Nonalcoholic Lipid Accumulation and Hepatocyte Malignant TransformationPathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathwaysAdvances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinomaContributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancerControlling liver cancer internationally: A qualitative study of clinicians' perceptions of current public policy needs.Inflammation in nonalcoholic steatohepatitis.Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma markerPrevalence of nonalcoholic steatohepatitis among patients with resectable intrahepatic cholangiocarcinoma.The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Translational approaches: from fatty liver to non-alcoholic steatohepatitis.Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional studyGlycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis.Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.The Gordian Knot of dysbiosis, obesity and NAFLD.Recent advances in dietary supplementation, in treating non-alcoholic fatty liver disease.Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease.A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy.Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up studyNAFLD and extrahepatic cancers: have a look at the colon.High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N mice.Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice.Primary hepatocellular carcinoma and metabolic syndrome: An update.Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeuticsMetabolic syndrome-related hepatocellular carcinoma treated by volumetric modulated arc therapy.Stereotactic body radiotherapy: an effective local treatment modality for hepatocellular carcinoma.Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization.Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention.The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment.The role of macrophages in obesity-driven chronic liver disease.Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.Obesity-associated digestive cancers: A review of mechanisms and interventions.The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort.Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.Cancer stem cells: repair gone awry?
P2860
Q26746521-C7CC1EA7-1067-467D-BEEE-1739047F141BQ26783372-5212E8B2-1F68-472A-A474-7C2BDB86E6A1Q26795529-8DC8A355-850B-490E-AFD6-473775A05479Q26992106-1C65CE04-B75F-4974-BF2C-3400C8BD94E3Q30226462-3D5BBF15-0C76-4B8C-8D28-F878ABC40082Q30453231-07CDAA3E-B04B-4B51-A61D-2E8A55E1B8C8Q31113966-13103988-E50B-4751-8B79-57DFA3A75787Q33554179-B3D237BA-9D46-49D7-BEBB-AE1C59EDA25AQ33798979-C0175840-36E0-41B8-99B0-B43F2EC5E84FQ33855157-06D8D0D1-ECEA-433C-ABDF-83637E4BDB62Q33958697-D78559A2-C4B4-46AB-89EA-1BDE18359F21Q34135529-1D6169B0-D5F6-42FC-ADDD-65D0AD184B91Q34137427-B2B895D0-0950-48D0-B442-40B06A09C051Q34241720-DB424548-8295-4792-A0EC-1FF6D35492E9Q34255487-AADE3230-2DBF-4F6D-9414-5ED62EA6090EQ34956813-0562011E-7053-4302-AB59-7D3CF4F050D6Q35127037-BD89FC29-4C17-48F5-8931-1C3C7DEC9C5BQ35532289-9C089C7D-6230-4CCA-989E-920AE69B6AFAQ35628824-0D3A2DF0-796C-4F51-8DE2-F4B40F2C34B3Q35933771-FB4A691A-BC3F-49BD-920D-6DE810D755C0Q36082328-CB416131-A4F0-4304-AE38-1681003FA7CBQ36747541-E96D0E03-CA72-4514-98AD-6CA753CE231EQ36800751-7451C005-5486-4CA9-89B1-A40E340CA323Q36937909-39A64913-E831-4BEA-B2BF-82691FE38AEBQ37137238-4636F65D-5188-447F-A4C8-6AA6AC744760Q37196508-3346E117-2254-4068-A55A-C8CFB9A2EA0EQ37355835-AB8AF2B5-7FB8-4F31-923E-F09EF8003552Q37719640-9953AC0D-AB05-42D6-893D-8FF8977ADC07Q38282463-66E61642-7398-450B-99E1-79DA18FE6771Q38552383-26BCA8B5-5218-4EF8-A908-0DF4674B528AQ38555120-293E99BD-C3BD-48B4-BF6D-655DE6EA1D62Q38584060-5C7860EA-0FD4-4024-ACFF-F978C266552AQ38645975-9B94A363-50D3-4E5F-9DFF-063849D0CF95Q38758810-29217891-ED3F-4AA6-92DE-FBB169E69C23Q38806090-81D2C459-9ADB-494E-83BF-22EC41E02617Q38972601-137017E2-FEAF-4821-8332-735646C3F2BBQ39205170-A5B84796-1516-495D-88FF-3302547F125BQ40174512-FF208864-5EF1-4075-A038-1425A2910BE6Q40208312-52ED0E69-C335-449B-AF19-E40AB31B9D16Q41216714-48AD5A99-D235-4E4B-92A5-E3CD6D762D5D
P2860
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@ast
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@en
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@nl
type
label
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@ast
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@en
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@nl
prefLabel
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@ast
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@en
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@nl
P356
P1433
P1476
Non-alcoholic fatty liver dise ...... : mechanisms and implications.
@en
P2093
Claus Hellerbrand
Felix Stickel
P304
P356
10.1136/GUT.2009.199661
P407
P577
2010-07-21T00:00:00Z